Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

26 May 2017 07:00

RNS Number : 2927G
Plant Health Care PLC
26 May 2017
 

26 May 2017

Plant Health Care plc

("Plant Health Care" or the "Company")

Director / PDMR Shareholdings

Plant Health Care (AIM: PHC) was notified that on 23 May 2017, Richard Webb, Executive Director of the Company, purchased a total of 106,530 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 30 pence per Ordinary Share. Following the purchase, Richard Webb is beneficially interested in 868,400 Ordinary Shares, representing approximately 0.59 per cent. of the Company's issued share capital.

PHC was further notified that on 23 May 2017, Joelle Jenny, the spouse of Richard Webb purchased a total of 80,825 Ordinary Shares at a price of 30 pence per Ordinary Share. Following the purchase, Joelle Jenny, is beneficially interested in 80,825 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital

 

Plant Health Care plc

Chris Richards - Executive Chairman and Interim CEO

Jeffrey Hovey - Chief Financial Officer

 

 

+1 919 926 1600

Liberum - Nomad and Broker

Clayton Bush

Chris Clarke

 

+44 (0) 203 100 2000

 

Company website: www.planthealthcare.com

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Dr. Richard H Webb

Joelle Jenny

2.

Reason for the Notification

a)

Position/status

Executive Director

Spouse of Executive Director, Richard Webb

b)

Initial notification/ Amendment

Initial notification

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

Plant Health Care plc

b)

LEI

pending

pending

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1 penny each

Ordinary Shares of 1 penny each

Identification code

GB00B01JC540

GB00B01JC540

b)

Nature of the transaction

Purchase of Ordinary shares

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume

Price

Volume

£0.30

106,530

£0.30

80,825

d)

Aggregated information:

·Aggregated volume

·Price

Single transaction as in 4c) above

106,530

£0.30

Single transaction as in 4c) above

80,825

£0.30

e)

Date of the transaction

23 May 2017

23 May 2017

f)

Place of the transaction

XLON

XLON

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSEIFMIFWSEDI
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.